相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Azacitidine for treatment of patients with myelodysplastic syndromes (MDS): practical recommendations of the German MDS Study Group
Katharina Goetze et al.
ANNALS OF HEMATOLOGY (2010)
Histone deacetylase inhibitors: A chemical genetics approach to understanding cellular functions
Paul A. Marks
BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2010)
Structure-activity relationship study of acridine analogs as haspin and DYRK2 kinase inhibitors
Gregory D. Cuny et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2010)
Polo-like Kinase 1 (Plk1) as a Novel Drug Target in Chronic Myeloid Leukemia: Overriding Imatinib Resistance with the Plk1 Inhibitor BI 2536
Karoline V. Gleixner et al.
CANCER RESEARCH (2010)
Mechanisms of Chromosomal Instability
Sarah L. Thompson et al.
CURRENT BIOLOGY (2010)
Aberrant Epigenetic Landscape in Cancer: How Cellular Identity Goes Awry
Maria Berdasco et al.
DEVELOPMENTAL CELL (2010)
Current and Future Management Options for Myelodysplastic Syndromes
Jeffrey Bryan et al.
DRUGS (2010)
Polo-like kinase inhibitors: an emerging opportunity for cancer therapeutics
Puneet Chopra et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2010)
Aurora Kinase Inhibitors - Rising Stars in Cancer Therapeutics?
Altaf A. Dar et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Two Histone Marks Establish the Inner Centromere and Chromosome Bi-Orientation
Yuya Yamagishi et al.
SCIENCE (2010)
Survivin Reads Phosphorylated Histone H3 Threonine 3 to Activate the Mitotic Kinase Aurora B
Alexander E. Kelly et al.
SCIENCE (2010)
Histone H3 Thr-3 Phosphorylation by Haspin Positions Aurora B at Centromeres in Mitosis
Fangwei Wang et al.
SCIENCE (2010)
Antitumor antibiotic fostriecin covalently binds to cysteine-269 residue of protein phosphatase 2A catalytic subunit in mammalian cells
Toshifumi Takeuchi et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2009)
Aurora-A and hBora Join the Game of Polo
Libor Macurek et al.
CANCER RESEARCH (2009)
AZD1152 Rapidly and Negatively Affects the Growth and Survival of Human Acute Myeloid Leukemia Cells In vitro and In vivo
Adedayo Oke et al.
CANCER RESEARCH (2009)
K858, a Novel Inhibitor of Mitotic Kinesin Eg5 and Antitumor Agent, Induces Cell Death in Cancer Cells
Ryuichiro Nakai et al.
CANCER RESEARCH (2009)
The aurora B kinase inhibitor AZD1152 sensitizes cancer cells to fractionated irradiation and induces mitotic catastrophe
Yungan Tao et al.
CELL CYCLE (2009)
Histone Deacetylase Inhibitors Current Status and Overview of Recent Clinical Trials
Xujun Ma et al.
DRUGS (2009)
The promises and pitfalls of epigenetic therapies in solid tumours
Janet S. Graham et al.
EUROPEAN JOURNAL OF CANCER (2009)
Studies of haspin-depleted cells reveal that spindle-pole integrity in mitosis requires chromosome cohesion
Jun Dai et al.
JOURNAL OF CELL SCIENCE (2009)
Histone Deacetylase Inhibitors in Cancer Therapy
Andrew A. Lane et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Identification of (1H)-pyrroles as histone deacetylase inhibitors with antitumoral activity
A. Zubia et al.
ONCOGENE (2009)
Crystal structure of the catalytic domain of Haspin, an atypical kinase implicated in chromatin organization
Fabrizio Villa et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Structure and functional characterization of the atypical human kinase haspin
Jeyanthy Eswaran et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Reversine, a novel Aurora kinases inhibitor, inhibits colony formation of human acute myeloid leukemia cells
Anna Morena D'Alise et al.
MOLECULAR CANCER THERAPEUTICS (2008)
The APC/C maintains the spindle assembly checkpoint by targeting Cdc20 for destruction
Jakob Nilsson et al.
NATURE CELL BIOLOGY (2008)
Centromeric Aurora-B activation requires TD-60, microtubules, and substrate priming phosphorylation
Sara E. Rosasco-Nitcher et al.
SCIENCE (2008)
CDK inhibitors in cancer therapy: what is next?
Marcos Malumbres et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2008)
Identification of Small Molecule Inhibitors of the Mitotic Kinase Haspin by High-Throughput Screening Using a Homogeneous Time-Resolved Fluorescence Resonance Energy Transfer Assay
Debasis Patnaik et al.
JOURNAL OF BIOMOLECULAR SCREENING (2008)
Pharmacological and functional comparison of the polo-like kinase family: Insight into inhibitor and substrate specificity
Eric F. Johnson et al.
BIOCHEMISTRY (2007)
Identification of griseofulvin as an inhibitor of centrosomal clustering in a phenotype-based screen
Blanka Rebacz et al.
CANCER RESEARCH (2007)
The spindle-assembly checkpoint in space and time
Andrea Musacchio et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Chromatin modifications and their function
Tony Kouzarides
CELL (2007)
Opinion - Angiogenesis: an organizing principle for drug discovery?
Judah Folkman
NATURE REVIEWS DRUG DISCOVERY (2007)
Regulation of mitotic chromosome cohesion by Haspin and Aurora B
Jun Dai et al.
DEVELOPMENTAL CELL (2006)
Validating Aurora B as an anti-cancer drug target
Fiona Girdler et al.
JOURNAL OF CELL SCIENCE (2006)
Selective small-molecule inhibitor reveals critical mitotic functions of human CDK1
Lyubomir T. Vassilev et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Molecular diagnosis of Burkitt's lymphoma
Sandeep S. Dave et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Anaphase Topsy-Turvy - Cdk1 a securin, separase a CK1
O Stemmann et al.
CELL CYCLE (2006)
The kinase haspin is required for mitotic histone H3 Thr 3 phosphorylation and normal metaphase chromosome alignment
J Dai et al.
GENES & DEVELOPMENT (2005)
VX-680, a potent and selective small-molecule inhibitor of the Aurora kinases, suppresses tumor growth in vivo
EA Harrington et al.
NATURE MEDICINE (2004)
Proadrenomedullin NH2-terminal 20 peptide is a potent angiogenic factor, and its inhibition results in reduction of tumor growth
A Martínez et al.
CANCER RESEARCH (2004)
Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia
A Rosenwald et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Haspin-like proteins: A new family of evolutionarily conserved putative eukaryotic protein kinases
JMG Higgins
PROTEIN SCIENCE (2001)
Histone deacetylases induce angiogenesis by negative regulation of tumor suppressor genes
MS Kim et al.
NATURE MEDICINE (2001)
分享论文
